ArticleThe Journal of infectious diseases2024

A Phase 1 Clinical Trial to Assess the Safety and Pharmacokinetics of a Tenofovir Alafenamide/Elvitegravir Insert Administered Rectally for HIV Prevention.

Sharon A Riddler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.